Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 11 Dehydroprostaglandin F2 Alpha
2. 11 Dehydroprostaglandin F2alpha
3. 11-dehydroprostaglandin F2 Alpha
4. 11-dehydroprostaglandin F2alpha
5. Alpha, 11-dehydroprostaglandin F2
6. D2, Prostaglandin
7. F2 Alpha, 11-dehydroprostaglandin
8. F2alpha, 11-dehydroprostaglandin
9. Pgd2
1. Pgd2
2. 41598-07-6
3. 11-dehydroprostaglandin F2-alpha
4. 11-dehydroprostaglandin F2alpha
5. Brn 2170623
6. (5z,13e,15s)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate
7. Rxy07s6cz2
8. (z)-7-[(1r,2r,5s)-5-hydroxy-2-[(e,3s)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic Acid
9. Chebi:15555
10. (5z,13e)-(15s)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate
11. 9s,15s-dihydroxy-11-oxo-5z,13e-prostadienoic Acid
12. [3h]pgd2
13. [3h]prostaglandin D2
14. Unii-rxy07s6cz2
15. (5z,13e)-(15s)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate
16. [3h]-pgd2
17. 11-dehydroprostaglandin F2 Alpha
18. Prosta-glandin D2
19. [3h]11-dehydroprostaglandin F2-alpha
20. Pgd2 (prostaglandin D2)
21. Bspbio_001486
22. Pg2
23. Bml1-f05
24. Gtpl1881
25. Gtpl1891
26. Schembl2508829
27. Chembl1235252
28. Bdbm21544
29. Dtxsid30897162
30. Hms1361k08
31. Hms1791k08
32. Hms1989k08
33. Hms3402k08
34. Hms3648m03
35. (5e,13e)-9,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic Acid
36. Lmfa03010004
37. Zinc85994848
38. Prostaglandin D2, >=95%, Synthetic
39. Prostaglandin D2, Cell Culture Tested
40. Db02056
41. Idi1_033956
42. Prosta-5,13-dien-1-oic Acid, 9,15-dihydroxy-11-oxo-, (5z,9-alpha,13e,15s)-
43. Ncgc00161284-01
44. Ncgc00161284-02
45. Ncgc00161284-03
46. Hy-101988
47. Cs-0022427
48. C00696
49. 9s,15s-dihydroxy-11-oxo-5z,13e-prostadienoate
50. Q419750
51. Sr-01000946237
52. Sr-01000946237-1
53. 9alpha,15s-dihydroxy-11-oxo-prosta-5z,13e-dien-1-oic Acid
54. E8965369-341a-46f4-8677-2ceb4f9432ba
55. (5z,13e)-(15s)-9,15-dihydroxy-11-oxoprosta-5,13-dienoate
56. (5z,13e)-(15s)-9,15-dihydroxy-11-oxoprosta-5,13-dienoic Acid
57. (5z,13e)-(15s)-9a,15-dihydroxy-11-oxoprosta-5,13-dienoate
58. (5z,13e)-(15s)-9a,15-dihydroxy-11-oxoprosta-5,13-dienoic Acid
59. (5z,13e,15s)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate
60. (5z,13e,15s)-9a,15-dihydroxy-11-oxoprosta-5,13-dien-1-oate
61. (5z,13e)-(15s)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoic Acid
62. (5z,13e)-(15s)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoic Acid
63. (5z,13e,15s)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoic Acid
64. (5z,13e,15s)-9a,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic Acid
65. (5z,13e,15s)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic Acid
66. (5z,9-alpha,13e,15s)-9,15-dihydroxy-11-oxo-prosta-5,13-dien-1-oate
67. (5z,9alpha,13e,15s)-9,15-dihydroxy-11-oxo-prosta-5,13-dien-1-oate
68. (5z,9alpha,13e,15s)-9,15-dihydroxy-11-oxo-prosta-5,13-dien-1-oic Acid
69. (5z,9alpha,13e,15s)-9,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic Acid
70. (5z,9-alpha,13e,15s)-9,15-dihydroxy-11-oxo-prosta-5,13-dien-1-oic Acid
71. 9,15- Dihydroxy-11-oxo-prosta-5,13-dien-1-oic Acid, (5z,9-.alpha.,13e,15s)
72. (5z)-7-[(1r,2r,5s)-5-hydroxy-2-[(1e,3s)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic Acid
Molecular Weight | 352.5 g/mol |
---|---|
Molecular Formula | C20H32O5 |
XLogP3 | 2.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 12 |
Exact Mass | 352.22497412 g/mol |
Monoisotopic Mass | 352.22497412 g/mol |
Topological Polar Surface Area | 94.8 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 469 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
74
PharmaCompass offers a list of Prostaglandin D2 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Prostaglandin D2 manufacturer or Prostaglandin D2 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Prostaglandin D2 manufacturer or Prostaglandin D2 supplier.
PharmaCompass also assists you with knowing the Prostaglandin D2 API Price utilized in the formulation of products. Prostaglandin D2 API Price is not always fixed or binding as the Prostaglandin D2 Price is obtained through a variety of data sources. The Prostaglandin D2 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid, including repackagers and relabelers. The FDA regulates 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid supplier is an individual or a company that provides 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid active pharmaceutical ingredient (API) or 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid finished formulations upon request. The 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid suppliers may include 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid API manufacturers, exporters, distributors and traders.
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid GMP manufacturer or 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid GMP API supplier for your needs.
A 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid CoA (Certificate of Analysis) is a formal document that attests to 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid's compliance with 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid specifications and serves as a tool for batch-level quality control.
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid CoA mostly includes findings from lab analyses of a specific batch. For each 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid may be tested according to a variety of international standards, such as European Pharmacopoeia (9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid EP), 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid USP).